What the FDA thinks is that anyone not living in the USA is a second class citizen. Especially Asians, they proved that during ADCOM when they ignored the JELIS study. Any Asian clinical studies, trials or scientific findings done by foreigners except Italian scientisits who design poor studies yet are taken as gospel by the FDA.